Company / Inventory
Glaukos Corp. Inventory History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory
$63.6M
FY2025
5-year range
$23.0M / $63.6M
FY2021-FY2025
Trend
+10.2%
vs FY2024
Sector context
#87 of 118
Health Care
What the data says
At $64M, Glaukos Corp.'s inventory ranks #87 of 118 in the Health Care sector. Inventory has increased for 5 consecutive years, from $16M in FY2020 to $64M in FY2025.
Based on SEC 10-K filings.
$64M in FY2025 with a 5-year CAGR of +32.1%.
Improved from $42M to $64M over the past 2 years.
Health Care sector context is included.
Inventory over time
Growth rates
- 3-Year CAGR
- +18.9%
- 5-Year CAGR
- +32.1%
- 10-Year CAGR
- -
Sector benchmark
#87 of 118 in Health CareTop 74% of 118This company $63.6M Sector average $1.4B
▼
-95.5% below sector average
Key checks
Key Insights
- Glaukos Corp.'s inventory has grown for 5 consecutive years.
- 5-year CAGR of +32.1%, indicating consistent growth.
- In FY2025, inventory increased 10.2% year-over-year.
- Ranks #87 out of 118 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | InventoryValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $63.6M | +10.2% |
| FY2024 | $57.7M | +37.4% |
| FY2023 | $42.0M | +11.0% |
| FY2022 | $37.8M | +64.4% |
| FY2021 | $23.0M | +45.6% |
| FY2020 | $15.8M | -62.9% |
| FY2019 | $42.6M | +220.6% |
| FY2018 | $13.3M | +18.4% |
| FY2017 | $11.2M | +64.0% |
| FY2016 | $6.8M | +67.0% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026